VRNS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Varonis Systems Inc (VRNS) is not a strong buy for a beginner, long-term investor at this moment. While the company has potential for growth in its SaaS transition and data security market, the ongoing legal issues, bearish technical indicators, and mixed analyst sentiment suggest caution. The investor's funds could be better allocated to assets with clearer growth trajectories and fewer uncertainties.
The stock's MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 61.714, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level of 24.249, with limited upside potential in the short term. The stock's historical trend suggests a 70% chance of minor declines in the next week and month.
Hedge funds are significantly increasing their positions in VRNS, with a 170.88% increase in buying activity last quarter.
Analysts from firms like Wells Fargo and DA Davidson see strong SaaS ARR growth potential and have issued Buy ratings with price targets in the $28-$30 range.
The company's Q4 financials showed revenue growth of 9.37% YoY and improved net income by 113.75% YoY.
Multiple class action lawsuits alleging revenue misrepresentation during the SaaS transition could lead to legal liabilities and investor distrust.
Analysts have lowered price targets significantly, citing uncertainties in ARR guidance and SaaS transition impacts.
Gross margin declined by 5.56% YoY, and the company remains unprofitable with a negative EPS of -0.24.
In Q4 2025, revenue grew by 9.37% YoY to $173.37M, and net income improved by 113.75% YoY to -$27.78M. However, the company remains unprofitable, with a negative EPS of -0.24. Gross margin dropped to 78.91%, down 5.56% YoY, indicating cost pressures.
Analyst sentiment is mixed. Recent upgrades from Wells Fargo and DA Davidson highlight strong SaaS ARR growth potential and data security demand. However, several firms, including Morgan Stanley and RBC Capital, have lowered price targets due to SaaS transition uncertainties and free cash flow headwinds. Price targets range from $27 to $38, with most clustering around $30.
